Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 74

1.

Influence of apolipoprotein E genotype on progression of diabetic nephropathy.

Joss N, Jardine A, Gaffney D, Boulton-Jones JM.

Nephron Exp Nephrol. 2005;101(4):e127-33. Epub 2005 Aug 19.

PMID:
16113584
2.

A prospective open-label randomised trial of quinapril and/or amlodipine in progressive non-diabetic renal failure.

MacGregor MS, Deighan CJ, Rodger RS, Boulton-Jones JM.

Nephron Clin Pract. 2005;101(3):c139-49. Epub 2005 Jul 5.

PMID:
16015004
3.

Treatment and outcome of adult patients with primary focal segmental glomerulosclerosis in five UK renal units.

Stirling CM, Mathieson P, Boulton-Jones JM, Feehally J, Jayne D, Murray HM, Adu D.

QJM. 2005 Jun;98(6):443-9. Epub 2005 May 6.

PMID:
15879445
4.

The link between circulating markers of endothelial function and proteinuria in patients with primary glomerulonephritis.

Mackinnon B, Deighan CJ, Norrie J, Boulton-Jones JM, Sattar N, Fox JG.

Clin Nephrol. 2005 Mar;63(3):173-80.

PMID:
15786817
5.

Intensified treatment of patients with type 2 diabetes mellitus and overt nephropathy.

Joss N, Ferguson C, Brown C, Deighan CJ, Paterson KR, Boulton-Jones JM.

QJM. 2004 Apr;97(4):219-27.

PMID:
15028852
6.

Diabetic nephropathy: how effective is treatment in clinical practice?

Joss N, Paterson KR, Deighan CJ, Simpson K, Boulton-Jones JM.

QJM. 2002 Jan;95(1):41-9.

PMID:
11834772
7.

The atherogenic lipoprotein phenotype: small dense LDL and lipoprotein remnants in nephrotic range proteinuria.

Deighan CJ, Caslake MJ, McConnell M, Boulton-Jones JM, Packard CJ.

Atherosclerosis. 2001 Jul;157(1):211-20.

PMID:
11427223
8.

Premature ageing and glomerulonephritis.

Joss N, Boulton-Jones JM, More I.

Nephrol Dial Transplant. 2001 Mar;16(3):615-8. Review. No abstract available.

PMID:
11239041
9.

Comparative effects of cerivastatin and fenofibrate on the atherogenic lipoprotein phenotype in proteinuric renal disease.

Deighan CJ, Caslake MJ, McConnell M, Boulton-Jones JM, Packard CJ.

J Am Soc Nephrol. 2001 Feb;12(2):341-8.

10.

Patients with nephrotic-range proteinuria have apolipoprotein C and E deficient VLDL1.

Deighan CJ, Caslake MJ, McConnell M, Boulton-Jones JM, Packard CJ.

Kidney Int. 2000 Sep;58(3):1238-46.

11.

Presentation, survival and prognostic markers in AA amyloidosis.

Joss N, McLaughlin K, Simpson K, Boulton-Jones JM.

QJM. 2000 Aug;93(8):535-42.

PMID:
10924536
12.

The hypertensive young lady with renal cysts--it is not always polycystic kidney disease.

McLaughlin K, Neilly JB, Fox JG, Boulton-Jones JM.

Nephrol Dial Transplant. 2000 Aug;15(8):1245-7. No abstract available.

PMID:
10910455
13.

Atherogenic lipoprotein phenotype in end-stage renal failure: origin and extent of small dense low-density lipoprotein formation.

Deighan CJ, Caslake MJ, McConnell M, Boulton-Jones JM, Packard CJ.

Am J Kidney Dis. 2000 May;35(5):852-62.

PMID:
10793019
14.

Aortic regurgitation caused by complex outflow calcification in a patient with chronic renal failure.

Geddes CC, Fox JG, Simpson K, Boulton-Jones JM.

Nephrol Dial Transplant. 1998 Dec;13(12):3230-2. No abstract available.

PMID:
9870500
15.

Progressive oedema in a 30-year-old.

Stirling CM, Boulton-Jones JM, Simpson K.

Lancet. 1998 Aug 8;352(9126):450. No abstract available.

PMID:
9708754
16.

Has the prognosis for patients with pauci-immune necrotizing glomerulonephritis improved?

McLaughlin K, Jerimiah P, Fox JG, Mactier RA, Simpson K, Boulton-Jones JM.

Nephrol Dial Transplant. 1998 Jul;13(7):1696-701.

PMID:
9681714
17.

Increased atherogenicity of low-density lipoprotein in heavy proteinuria.

Deighan CJ, Caslake MJ, McConnell M, Boulton-Jones JM, Packard CJ.

Nephrol Dial Transplant. 1998 May;13(5):1183-8.

PMID:
9623551
18.

Immunosuppression and outcome in idiopathic membranous nephropathy.

Stirling CM, Simpson K, Boulton-Jones JM.

QJM. 1998 Feb;91(2):159-64.

PMID:
9578897
19.

An artificial neural network can select patients at high risk of developing progressive IgA nephropathy more accurately than experienced nephrologists.

Geddes CC, Fox JG, Allison ME, Boulton-Jones JM, Simpson K.

Nephrol Dial Transplant. 1998 Jan;13(1):67-71.

PMID:
9481717
20.

The influence of familial factors on the progression of IgA nephropathy.

Geddes CC, Warwick GL, Tulloch I, Boulton-Jones JM.

Nephrol Dial Transplant. 1997 Sep;12(9):1963-7.

PMID:
9306351

Supplemental Content

Loading ...
Support Center